GoodRx Holdings, Inc. GDRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $787.89M-1.1% | $796.85M-0.5% | $800.65M+0.1% | $799.87M+0.3% | $797.41M+0.6% | ||
| $64.39M+11.8% | $57.6M+10.1% | $52.33M+3.4% | $50.59M+3.0% | $49.11M+1.9% | ||
| $723.5M-2.1% | $739.26M-1.2% | $748.33M-0.1% | $749.28M+0.1% | $748.3M+0.6% | ||
| 91.8%-0.9pp | 92.8%-0.7pp | 93.5%-0.2pp | 93.7%-0.2pp | 93.8%-0.1pp | ||
| $120.06M-0.8% | $121.03M-2.3% | $123.83M+0.7% | $122.95M-0.7% | $123.87M+0.1% | ||
| $328.07M-1.1% | $331.56M-4.4% | $346.77M-1.8% | $353.11M-2.4% | $361.69M-1.5% | ||
| $111.15M-2.5% | $113.96M+0.3% | $113.57M+6.0% | $107.17M+0.7% | $106.38M-9.7% | ||
| $86.1M+1.0% | $85.22M+5.0% | $81.17M+5.0% | $77.27M+3.7% | $74.51M+7.1% | ||
| $709.77M+0.1% | $709.36M-1.2% | $717.66M+0.9% | $711.1M-0.6% | $715.57M-1.5% | ||
| $78.12M-10.7% | $87.49M+5.4% | $82.99M-6.5% | $88.78M+8.5% | $81.85M+24.3% | ||
| 9.9%-1.1pp | 11%+0.6pp | 10.4%-0.7pp | 11.1%+0.8pp | 10.3%+2.0pp | ||
| $41.73M-2.1% | $42.61M-2.2% | $43.56M-3.4% | $45.09M-7.8% | $48.92M-7.6% | ||
| $8.4M-23.2% | $10.93M-19.8% | $13.63M-15.4% | $16.12M-18.0% | $19.65M-15.6% | ||
| -$32.61M-5.4% | -$30.95M-5.9% | -$29.24M+11.4% | -$33.01M+2.9% | -$34.01M+1.1% | ||
| $45.51M-19.5% | $56.54M+5.2% | $53.75M-3.6% | $55.77M+16.6% | $47.84M+52.1% | ||
| $24.95M-4.4% | $26.1M+18.6% | $22M+3.9% | $21.17M+9.2% | $19.38M+28.6% | ||
| $20.56M-32.5% | $30.44M-4.1% | $31.75M-8.2% | $34.6M+21.6% | $28.45M+73.6% | ||
| 2.6%-1.2pp | 3.8%-0.1pp | 4%-0.4pp | 4.3%+0.8pp | 3.6%+1.5pp | ||
| $0.06-33.3% | $0.090.0% | $0.09-10.0% | $0.10+25.0% | $0.08+60.0% | ||
| $0.06-33.3% | $0.09+12.5% | $0.08-11.1% | $0.09+28.6% | $0.07+75.0% | ||
| 1.4B-2.7% | 1.4B-2.4% | 1.5B-2.7% | 1.5B-1.8% | 1.5B-0.7% | ||
| 1.4B-2.7% | 1.4B-2.0% | 1.5B-2.2% | 1.5B-1.3% | 1.5B-0.7% | ||
| $8.4M-23.2% | $10.93M-19.8% | $13.63M-15.4% | $16.12M-18.0% | $19.65M-15.6% | ||
| $787.89M-1.1% | $796.85M-0.5% | $800.65M+0.1% | $799.87M+0.3% | $797.41M+0.6% | ||
| $78.12M-10.7% | $87.49M+5.4% | $82.99M-6.5% | $88.78M+8.5% | $81.85M+24.3% | ||
| $164.22M-4.9% | $172.71M+5.2% | $164.16M-1.1% | $166.05M+6.2% | $156.35M+15.5% | ||
| $164.22M-4.9% | $172.71M+5.2% | $164.16M-1.1% | $166.05M+6.2% | $156.35M+15.5% | ||
| 20.8%-0.8pp | 21.7%+1.2pp | 20.5%-0.3pp | 20.8%+1.2pp | 19.6%+2.5pp | ||
| $78.12M-10.7% | $87.49M+5.4% | $82.99M-6.5% | $88.78M+8.5% | $81.85M+24.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is GoodRx Holdings, Inc.'s revenue?
- GoodRx Holdings, Inc. (GDRX) generated $787.9M in revenue over the trailing twelve months, down 1.2% year over year.
- Is GoodRx Holdings, Inc. profitable?
- GoodRx Holdings, Inc. reported $20.6M in net income over the trailing twelve months, a 2.6% net margin.
- What are GoodRx Holdings, Inc.'s profit margins?
- Gross margin is 91.8% and operating margin is 9.9%, with a 2.6% net margin.
- What is GoodRx Holdings, Inc.'s earnings per share?
- GoodRx Holdings, Inc.'s diluted EPS over the trailing twelve months is $0.06.
- Where does GoodRx Holdings, Inc.'s income statement data come from?
- Every line is extracted from GoodRx Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
